Perez-Fidalgo, J., Iglesias, M., Bohn, U., Calve, E., Garcia, Y., Guerra, E., . . . Gonzalez-Martin, A. (2019). GEICO1601-ROLANDO: A multicentric single arm Phase II clinical trial to evaluate the combination of olaparib and pegylated liposomal doxorubicin for platinum-resistant ovarian cancer.
Citación estilo ChicagoPerez-Fidalgo, JA, M. Iglesias, U. Bohn, E. Calve, Y. Garcia, E. Guerra, L. Manso, A. Santaballa, y A. Gonzalez-Martin. GEICO1601-ROLANDO: A Multicentric Single Arm Phase II Clinical Trial to Evaluate the Combination of Olaparib and Pegylated Liposomal Doxorubicin for Platinum-resistant Ovarian Cancer. 2019.
Cita MLAPerez-Fidalgo, JA, et al. GEICO1601-ROLANDO: A Multicentric Single Arm Phase II Clinical Trial to Evaluate the Combination of Olaparib and Pegylated Liposomal Doxorubicin for Platinum-resistant Ovarian Cancer. 2019.